Paul Herendeen - Net Worth and Insider Trading

Paul Herendeen Net Worth

The estimated net worth of Paul Herendeen is at least $2 Million dollars as of 2024-11-13. Paul Herendeen is the EVP and CFO of Bausch Health Companies Inc and owns about 226,866 shares of Bausch Health Companies Inc (BHC) stock worth over $2 Million. Paul Herendeen is also the Director of Elanco Animal Health Inc and owns about 17,307 shares of Elanco Animal Health Inc (ELAN) stock worth over $245,586. Details can be seen in Paul Herendeen's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Paul Herendeen has not made any transactions after 2022-09-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Paul Herendeen

To

Paul Herendeen Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Paul Herendeen owns 3 companies in total, including Bausch Health Companies Inc (BHC) , Zoetis Inc (ZTS) , and Elanco Animal Health Inc (ELAN) .

Click here to see the complete history of Paul Herendeen’s form 4 insider trades.

Insider Ownership Summary of Paul Herendeen

Ticker Comapny Transaction Date Type of Owner
BHC Bausch Health Companies Inc 2018-09-14 EVP and CFO
ZTS Zoetis Inc 2014-09-02 Exec. V.P. and CFO
ELAN Elanco Animal Health Inc 2022-09-09 director

Paul Herendeen Latest Holdings Summary

Paul Herendeen currently owns a total of 2 stocks. Among these stocks, Paul Herendeen owns 226,866 shares of Bausch Health Companies Inc (BHC) as of September 14, 2018, with a value of $2 Million and a weighting of 89.02%. Paul Herendeen also owns 17,307 shares of Elanco Animal Health Inc (ELAN) as of September 9, 2022, with a value of $245,586 and a weighting of 10.98%.

Latest Holdings of Paul Herendeen

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BHC Bausch Health Companies Inc 2018-09-14 226,866 8.78 1,991,883
ELAN Elanco Animal Health Inc 2022-09-09 17,307 14.19 245,586

Holding Weightings of Paul Herendeen


Paul Herendeen Form 4 Trading Tracker

According to the SEC Form 4 filings, Paul Herendeen has made a total of 0 transactions in Bausch Health Companies Inc (BHC) over the past 5 years. The most-recent trade in Bausch Health Companies Inc is the acquisition of 10,000 shares on September 14, 2018, which cost Paul Herendeen around $226,100.

According to the SEC Form 4 filings, Paul Herendeen has made a total of 1 transactions in Elanco Animal Health Inc (ELAN) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Elanco Animal Health Inc is the acquisition of 10,000 shares on September 9, 2022, which cost Paul Herendeen around $150,300.

Insider Trading History of Paul Herendeen

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Paul Herendeen Trading Performance

GuruFocus tracks the stock performance after each of Paul Herendeen's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Paul Herendeen is 17.07%. GuruFocus also compares Paul Herendeen's trading performance to market benchmark return within the same time period. The performance of stocks bought by Paul Herendeen within 3 months outperforms 3 times out of 4 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Paul Herendeen's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Paul Herendeen

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
3 out of 4 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -3.52 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 1.67 LIMIT LIMIT LIMIT LIMIT LIMIT

Paul Herendeen Ownership Network

Ownership Network List of Paul Herendeen

No Data

Ownership Network Relation of Paul Herendeen

Insider Network Chart

Paul Herendeen Owned Company Details

What does Bausch Health Companies Inc do?

Who are the key executives at Bausch Health Companies Inc?

Paul Herendeen is the EVP and CFO of Bausch Health Companies Inc. Other key executives at Bausch Health Companies Inc include EVP & General Counsel Seana Carson , SVP & Controller & CAO John S Barresi , and EVP & Chief Financial Officer Tom George Vadaketh .

Bausch Health Companies Inc (BHC) Insider Trades Summary

Over the past 18 months, Paul Herendeen made no insider transaction in Bausch Health Companies Inc (BHC). Other recent insider transactions involving Bausch Health Companies Inc (BHC) include a net sale of 20,318 shares made by Seana Carson ,

In summary, during the past 3 months, insiders sold 13,370 shares of Bausch Health Companies Inc (BHC) in total and bought 0 shares, with a net sale of 13,370 shares. During the past 18 months, 20,318 shares of Bausch Health Companies Inc (BHC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 20,318 shares.

Bausch Health Companies Inc (BHC)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Bausch Health Companies Inc Insider Transactions

No Available Data

Paul Herendeen Mailing Address

Above is the net worth, insider trading, and ownership report for Paul Herendeen. You might contact Paul Herendeen via mailing address: C/o Bausch Health Companies Inc., 400 Somerset Corporate Blvd., Bridgewater Nj 08807.